Identification of inflammatory biomarkers in predicting second events in patients with coronary artery diseases
Not Applicable
- Conditions
- Health Condition 1: I20-I25- Ischemic heart diseases
- Registration Number
- CTRI/2020/02/023122
- Lead Sponsor
- Manipal Academy of Higher Education
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients clinically diagnosed as having CAD (with or without MI) between 18 to 65 years of age who are willing to participate will be recruited.
Exclusion Criteria
Patients who had trauma or major surgery within last 4 weeks, pregnancy, intravenous drug abuse and anemia (Hemoglobin less than 10mg/dL) will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of a robust biomarker panel to effectively risk stratify individuals to predict the onset of asymptomatic coronary artery disease and to predict the occurrence of a future MACE in patients with diagnosed CADs. This could lead to stringent prophylactic interventions in susceptible individuals and effectively control the precipitation of a cardiac event.Timepoint: 0 months, 3 months, 6 months, 9 months, 12 months
- Secondary Outcome Measures
Name Time Method Development of risk stratification cut offs of inflammatory markers in asymptomatic patients without any known history of coronary artery diseaseTimepoint: 12 months